These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 8388197

  • 1. Mutations in the gyrA gene of a highly fluoroquinolone-resistant clinical isolate of Escherichia coli.
    Heisig P, Schedletzky H, Falkenstein-Paul H.
    Antimicrob Agents Chemother; 1993 Apr; 37(4):696-701. PubMed ID: 8388197
    [Abstract] [Full Text] [Related]

  • 2. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.
    Ouabdesselam S, Hooper DC, Tankovic J, Soussy CJ.
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1667-70. PubMed ID: 7486897
    [Abstract] [Full Text] [Related]

  • 3. Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.
    Cambau E, Bordon F, Collatz E, Gutmann L.
    Antimicrob Agents Chemother; 1993 Jun; 37(6):1247-52. PubMed ID: 8392306
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
    Ozeki S, Deguchi T, Yasuda M, Nakano M, Kawamura T, Nishino Y, Kawada Y.
    J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
    Ito H, Yoshida H, Bogaki-Shonai M, Niga T, Hattori H, Nakamura S.
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012
    [Abstract] [Full Text] [Related]

  • 10. Analysis of the mutations involved in fluoroquinolone resistance of in vivo and in vitro mutants of Escherichia coli.
    Bachoual R, Tankovic J, Soussy CJ.
    Microb Drug Resist; 1998 Sep; 4(4):271-6. PubMed ID: 9988045
    [Abstract] [Full Text] [Related]

  • 11. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
    Kumagai Y, Kato JI, Hoshino K, Akasaka T, Sato K, Ikeda H.
    Antimicrob Agents Chemother; 1996 Mar; 40(3):710-14. PubMed ID: 8851598
    [Abstract] [Full Text] [Related]

  • 12. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli.
    Heisig P.
    Antimicrob Agents Chemother; 1996 Apr; 40(4):879-85. PubMed ID: 8849244
    [Abstract] [Full Text] [Related]

  • 13. Association between double mutation in gyrA gene of ciprofloxacin-resistant clinical isolates of Escherichia coli and MICs.
    Vila J, Ruiz J, Marco F, Barcelo A, Goñi P, Giralt E, Jimenez de Anta T.
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2477-9. PubMed ID: 7840592
    [Abstract] [Full Text] [Related]

  • 14. In vitro selection of fluoroquinolone-resistant Neisseria gonorrhoeae harboring alterations in DNA gyrase and topoisomerase IV.
    Yasuda M, Fukuda H, Yokoi S, Ishihara S, Kawada Y, Deguchi T.
    J Urol; 2000 Sep; 164(3 Pt 1):847-51. PubMed ID: 10953166
    [Abstract] [Full Text] [Related]

  • 15. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
    Bagel S, Hüllen V, Wiedemann B, Heisig P.
    Antimicrob Agents Chemother; 1999 Apr; 43(4):868-75. PubMed ID: 10103193
    [Abstract] [Full Text] [Related]

  • 16. Characterization of clinical isolates of Escherichia coli showing high levels of fluoroquinolone resistance.
    Lehn N, Stower-Hoffmann J, Kott T, Strassner C, Wagner H, Kronke M, Schneider-Brachert W.
    J Clin Microbiol; 1996 Mar; 34(3):597-602. PubMed ID: 8904422
    [Abstract] [Full Text] [Related]

  • 17. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
    Aleixandre V, Urios A, Herrera G, Blanco M.
    Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316
    [Abstract] [Full Text] [Related]

  • 18. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae.
    Weigel LM, Steward CD, Tenover FC.
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2661-7. PubMed ID: 9756773
    [Abstract] [Full Text] [Related]

  • 19. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
    Kocagöz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF.
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1768-74. PubMed ID: 8843279
    [Abstract] [Full Text] [Related]

  • 20. Contributions of individual mechanisms to fluoroquinolone resistance in 36 Escherichia coli strains isolated from humans and animals.
    Everett MJ, Jin YF, Ricci V, Piddock LJ.
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2380-6. PubMed ID: 8891148
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.